amikacin therapi exacerb pseudomona aeruginosa infect patient cystic fibrosi amikacin new semisynthet aminoglycosid antibiot activ pseudomona aeruginosa wa use treat 22 acut exacerb chronic pulmonari infect 18 patient cystic fibrosi patient rang 5 32 year age mucoid p aeruginosa isol sputum amikacin dose wa usual 75 mgkg everi eight hour wa increas 10 mgkg andor carbenicillin wa ad select case depend clinic cours although p aeruginosa wa elimin patient sputum except two case wa good clinic respons 19 22 cours signific improv chest xray film spirometri arteri oxygen tension wa document 11 17 cours one instanc serum creatinin level elev could attribut thi antibiot two patient show minim 15 db unilater highfrequ hear loss serial audiogram activ mani gentamicinresist strain high blood level among attract properti amikacin amikacin clinic effect treat pseudomonasassoci pulmonari infect complic cystic fibrosi